Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 6 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

33%

1 of 3 completed trials have results

Key Signals

1 with results

Enrollment Performance

Analytics

N/A
5(100.0%)
5Total
N/A(5)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (6)

Showing 6 of 6 trials
NCT02807545Not ApplicableCompleted

Scoliosis-Specific Exercises for At-Risk AIS Curves

Role: collaborator

NCT01792609Not ApplicableCompleted

Min Implants Max Outcomes Clinical Trial

Role: collaborator

NCT01776125Completed

Genetic Evaluation of NF1 and Scoliosis Patients

Role: collaborator

NCT03688438Not ApplicableUnknown

WoundVac in Obese Patients Undergoing Lumbar Surgery

Role: lead

NCT02703831Not ApplicableUnknown

Single Versus Dual Spine Attending Surgeons in Complex Adult Deformity Surgery:

Role: lead

NCT01453309Not ApplicableUnknown

Cost Effectiveness and Clinical Utility of Cell Saver Use for Two to Three Level Lumbar Fusions

Role: lead

All 6 trials loaded